Document Detail


Cost-effectiveness of two endovascular treatment strategies vs intravenous thrombolysis.
MedLine Citation:
PMID:  23278859     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: To assess the cost-effectiveness of endovascular treatment against intravenous thrombolysis (IVT) when varying assumptions concerning its effectiveness. METHODS: We developed a health economic model including a hypothetical population consisting of patients with ischemic stroke, admitted within 4.5 h from onset, without contraindications for IVT or intra-arterial treatment (IAT). A decision tree and life table were used to assess 6-month and lifetime costs (in Euros) and effects in quality-adjusted life years treatment with IVT alone, IAT alone, and IVT followed by IAT if the patient did not respond to treatment. Several analyses were performed to explore the impact of considerable uncertainty concerning the clinical effectiveness of endovascular treatment. RESULTS: Probabilistic sensitivity analysis demonstrated a 54% probability of positive incremental lifetime effectiveness of IVT-IAT vs IVT alone. Sensitivity analyses showed significant variation in outcomes and cost-effectiveness of the included treatment strategies at different model assumptions. CONCLUSIONS: Acceptable cost-effectiveness of IVT-IAT compared to IVT will only be possible if recanalization rates are sufficiently high (>50%), treatment costs of IVT-IAT do not increase, and complication rates remain similar to those reported in the few randomized studies published to date. Large randomized studies are needed to reduce the uncertainty concerning the effects of endovascular treatment.
Authors:
J C Bouvy; P S S Fransen; S A Baeten; M A Koopmanschap; L W Niessen; D W J Dippel
Related Documents :
24193079 - Patient engagement programs for recognition and initial treatment of depression in prim...
24186909 - Neurology residency program as factor associated with thrombolysis utilization in acute...
19922649 - A prospective, randomized, double-blind, placebo-controlled parallel-group dual site tr...
23267529 - Relationship between depressive symptom severity and emergency department use among low...
23417609 - The economic burden of depression in switzerland.
14499439 - Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable...
12749519 - A model analysis of costs of blood pressure destabilization and edema associated with r...
19717829 - Attitudes of veterinary students to pain in cattle.
25121399 - Effects of mycoplasmal upper-respiratory-tract disease on movement and thermoregulatory...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-31
Journal Detail:
Title:  Acta neurologica Scandinavica     Volume:  -     ISSN:  1600-0404     ISO Abbreviation:  Acta Neurol. Scand.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2013-1-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370336     Medline TA:  Acta Neurol Scand     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Affiliation:
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Health Policy and Management (iBMG), Institute for Medical Technology Assessment, Erasmus MC Rotterdam, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subject...
Next Document:  Osmotic demyelination syndrome associated with hypophosphataemia: 2 cases and a review of literature...